TIM
ADVM

Tortoise Investment Management’s Adverum Biotechnologies ADVM Stock Holding History

Tortoise Investment Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-200
Closed -$19K – 394
2015
Q4 		$19K Hold
200
– – 0.01% 266
2015
Q3 		$16K Hold
200
– – 0.01% 267
2015
Q2 		$32K Sell
200
-66
-25% -$22.3K 0.01% 234
2015
Q1 		$108K Buy
+266
New +$112K 0.04% 147

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Tortoise Investment Management's ADVM Position: Q1 2016 in Review

Tortoise Investment Management sold out of Adverum Biotechnologies (ADVM) in Q1 2016, closing a stake of 200 shares — an estimated $19K sold.

Tortoise Investment Management first reported a position in ADVM in Q1 2015 and held it in 4 quarters. The position peaked at $108K in Q1 2015. 82 funds tracked by Wall St. Rank hold ADVM as of Q1 2016.

  • Tortoise Investment Management reported no remaining Adverum Biotechnologies position as of Q1 2016 after selling out during the quarter.
  • Tortoise Investment Management sold 200 Adverum Biotechnologies shares in Q1 2016, an estimated $19K.
  • Tortoise Investment Management first reported a position in Adverum Biotechnologies in Q1 2015 and held it in 4 quarters.
  • Tortoise Investment Management's Adverum Biotechnologies position peaked at $108K in Q1 2015.
  • 82 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q1 2016.

Based on Tortoise Investment Management's 13F filing for Q1 2016, filed 6 May 2016.